Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Efficacy of oral versus vaginal misoprostol in the management of first trimester incomplete miscarriage.

View through CrossRef
Objective: To compare the efficacy of oral versus vaginal misoprostol in first trimester incomplete miscarriage. Study Design: Cross-sectional study. Setting: Gynae B Unit of Lady Reading Hospital, Peshawar. Period: November 2017 to January 2018. Material & Methods: In this study 274 patients (i.e. 137 in each group) with incomplete miscarriage, who have gestational age of less than or equal to 12 weeks were included by convenience sampling. Women in group A had received 800 microgram oral misoprostol and women in group B had received 800 microgram vaginal misoprostol. In both groups same dose was repeated 4 hours after initial dose if the patient had not passed the product of conception. Patient who had no products of conception on pelvic ultrasound or Transvaginal scan were discharged from hospital. On the other hand patients found to still have products of conception were managed by surgical evacuation on next day. Results: In Group A (oral misoprostol) was effective in n=115 (84%) patients and ineffective in n=22(16%) patients and Group B (vaginal misoprostol) was effective in n= 125(91%) patients and ineffective in n=12(9%) patients. No significant difference was found between the efficacies of the two routes. Age distribution among two groups was analyzed as in Group A mean age was 23.9±3.7 years while in Group B it was 23.7±3.9 years. Mean gestational age in group A was 68.8±1.6 days and in group B was 68.7±1.3 days. Insignificant difference was found when the age and gestational age of the patients of group A and B were compared. Conclusion: Vaginal misoprostol is equally effective as oral misoprostol in terms of expulsion of products of conception in patients with incomplete miscarriage.
Title: Efficacy of oral versus vaginal misoprostol in the management of first trimester incomplete miscarriage.
Description:
Objective: To compare the efficacy of oral versus vaginal misoprostol in first trimester incomplete miscarriage.
Study Design: Cross-sectional study.
Setting: Gynae B Unit of Lady Reading Hospital, Peshawar.
Period: November 2017 to January 2018.
Material & Methods: In this study 274 patients (i.
e.
137 in each group) with incomplete miscarriage, who have gestational age of less than or equal to 12 weeks were included by convenience sampling.
Women in group A had received 800 microgram oral misoprostol and women in group B had received 800 microgram vaginal misoprostol.
In both groups same dose was repeated 4 hours after initial dose if the patient had not passed the product of conception.
Patient who had no products of conception on pelvic ultrasound or Transvaginal scan were discharged from hospital.
On the other hand patients found to still have products of conception were managed by surgical evacuation on next day.
Results: In Group A (oral misoprostol) was effective in n=115 (84%) patients and ineffective in n=22(16%) patients and Group B (vaginal misoprostol) was effective in n= 125(91%) patients and ineffective in n=12(9%) patients.
No significant difference was found between the efficacies of the two routes.
Age distribution among two groups was analyzed as in Group A mean age was 23.
9±3.
7 years while in Group B it was 23.
7±3.
9 years.
Mean gestational age in group A was 68.
8±1.
6 days and in group B was 68.
7±1.
3 days.
Insignificant difference was found when the age and gestational age of the patients of group A and B were compared.
Conclusion: Vaginal misoprostol is equally effective as oral misoprostol in terms of expulsion of products of conception in patients with incomplete miscarriage.

Related Results

Giant Sacrococcygeal Teratoma in Infant: Systematic Review
Giant Sacrococcygeal Teratoma in Infant: Systematic Review
Abstract Introduction Sacrococcygeal teratoma (SCT) is a rare embryonal tumor that occurs in the sacrococcygeal region, with an incidence of about 1 in 35,000 to 40,000 live births...
Efficacy of Single Dose of 800µg Vaginal Misoprostol in the Induction of First Trimester Abortion
Efficacy of Single Dose of 800µg Vaginal Misoprostol in the Induction of First Trimester Abortion
Background: Dissolution of pregnancy in the first trimester for several maternal as well as foetal concerns (therapeutic abortion) is a common obstetrical issue. However, induction...
Potentially acute misoprostol toxicity during third-trimester pregnancy: a case report
Potentially acute misoprostol toxicity during third-trimester pregnancy: a case report
Background: The International Federation of Gynecology and Obstetrics (FIGO) recommends the dosage of misoprostol for pregnancy termination in >28 weeks is 25 mcg to 100 mcg per...
Effectiveness, safety and acceptability of outpatient medical treatment of first trimester miscarriage.
Effectiveness, safety and acceptability of outpatient medical treatment of first trimester miscarriage.
Objective: To evaluate the effectiveness, safety and acceptability of outpatient medical treatment of first trimester miscarriage with misoprostol. Study Design: Descriptive Longit...
Therapeutic effect of mifepristone combined with misoprostol in early missed miscarriage and prediction of incomplete abortion
Therapeutic effect of mifepristone combined with misoprostol in early missed miscarriage and prediction of incomplete abortion
Objective: To compare the clinical efficacy of mifepristonemisoprostol medical management versus surgical curettage for first-trimester missed miscarriage, and to estab...

Back to Top